Results 131 to 140 of about 748,383 (382)
Effects of melanotropic peptides on fetal adrenal gland. [PDF]
Daniel Rudman +3 more
openalex +1 more source
CT Findings in Mycobacterial and Fungal Infection of the Adrenal Glands
Nanthicha Termboonphati +4 more
openalex +2 more sources
Wearable biosensors based on molecularly imprinted polymers
Wearable biosensors based on molecularly imprinted polymers (MIPs) provide real‐time, non‐invasive monitoring of key biomarkers. This review highlights the research advances on MIPs‐based biosensors with enhanced selectivity, stability, and adaptability in flexible sensing platforms.
Xiangnan Li +3 more
wiley +1 more source
Molecular imprinting for neurology: Materials, applications, and limitations
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma +3 more
wiley +1 more source
Pediatric Endocrine Hypertension Related to the Adrenal Glands. [PDF]
Kim HY, Kim J.
europepmc +1 more source
What's New? Breast cancer results from a combination of genetic and environmental causes, and the cumulative effect of stressful life events may be a contributing factor. Here, the authors analyzed data from cohort and twin‐pair studies including 36 years of follow‐up to find out how stressful life events affect breast cancer risk. They found that even
Elissar Azzi +5 more
wiley +1 more source
The adrenal glands are complex endocrine glands regulating multiple physiological processes in the animal body. This study was carried out on the adrenal glands during two postnatal periods of a local rabbit.
Ahmed Abdulla Hussein, et al.
doaj
What's New? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke +30 more
wiley +1 more source
What's New? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel +21 more
wiley +1 more source
Asymmetries of Left and Right Adrenal Glands in Neural Innervation and Glucocorticoids Production. [PDF]
Saxu R, Yang Y, Gu HF.
europepmc +1 more source

